Verzenio Side Effects: What Patients Are Reporting

Verzenio Side Effects: What Patients Are Reporting

Matthew Goetz, MD, talks about patient-reported Verzenio side effects and how to manage diarrhea caused by Verzenio.
Dec 11, 2018

Dr. Matthew Goetz discusses the research he presented at the 2018 San Antonio Breast Cancer Symposium on patient-reported outcomes from women being treated with Verzenio (chemical name: abemaciclib) plus an aromatase inhibitor as the first treatment for advanced-stage, hormone-receptor-positive, HER2-negative breast cancer.

Listen to the podcast to hear Dr. Goetz talk about:

  • what patient-reported outcomes are and why they're important for both doctors and patients

  • the Verzenio side effects reported in the study

  • how diarrhea caused by Verzenio can be proactively managed so a woman doesn't have to plan her life around a side effect

About the guest
Matthew Goetz headshot
Matthew Goetz, MD

Dr. Matthew Goetz is a professor of oncology at the Mayo Clinic where he is also co-leader of the Women's Cancer Program and chair of the Breast Cancer Disease-Oriented Group.

— Last updated on June 29, 2022, 2:58 PM


This content made possible by Lilly Oncology.

Support to produce more content like this

Your donation goes directly to what you read, hear, and see on